JR
Therapeutic Areas
LB Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| LB-102 | Schizophrenia | Phase 2 |
Leadership Team at LB Pharmaceuticals
HT
Heather Turner, J.D.
Chief Executive Officer and Director
AE
Anna Eramo, M.D.
Chief Medical Officer
KP
Kaya Pai Panandiker
Chief Commercial Officer
GS
Gad Soffer
Chief Business Officer
MP
Minako Pazdera, J.D., Ph.D.
General Counsel
LB
Lindsay Beaupre
Senior Vice President, People and Culture
MP
Marc Panoff
Senior Vice President, Finance
ER
Ellen Rose
Senior Vice President, Corporate Affairs
RA
Richard A. Silva, Ph.D.
Senior Vice President, Technical Operations
JM
John M. Kane, M.D.
Chairman, Scientific Advisory Board